Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of a Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
NCT03576001Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Aug 2019
- Primary completion
- Jan 2025
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of testosterone undecanoate in spinal cord injury (SCI), sponsored by Brigham and Women's Hospital. Started Aug 2019; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT03576001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03576001.